The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

As one of the world’s largest biopharma companies, Pfizer ($PFE) is no stranger to leveraging market dynamics to benefit the company and its ...

We recently published 11 Stocks Crushing Wall Street With Whopping Gains. GSK plc (NYSE:GSK) is one of the top performers on ...

Outgoing CEO Walmsley's bold R&D push ignites investor buzz as AstraZeneca and GSK shares jump on deal optimism ...

Emma Walmsley was the first woman to hold the CEO post at the Big Pharma company.

GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

The new metro-level data launches alongside Vaccine Track’s Q1 2025 insights , which reveal wide variation in adult vaccination across communities. While most metro areas experienced increases in Q1 ...

The agreement, seen as less punishing than some within the industry had feared, gives hard-hit global drugmakers a degree of ...

McCarter & English launched a wave of patent infringement lawsuits on behalf of biotech giants in Delaware federal court this ...

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...

GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower ...